Wealth Enhancement Advisory Services, LLC Nektar Therapeutics Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 60,371 shares of NKTR stock, worth $42,259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,371Holding current value
$42,259% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NKTR
# of Institutions
168Shares Held
123MCall Options Held
1.18MPut Options Held
64.6K-
Black Rock Inc. New York, NY15.2MShares$10.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$8.62 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT7.79MShares$5.45 Million0.24% of portfolio
-
Acadian Asset Management LLC Boston, MA7.3MShares$5.11 Million0.01% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.65MShares$4.66 Million0.1% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $131M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...